In this issue:
177Lu-PSMA-617 plus enzalutamide for mCRPC
AS uptake in men with low-risk prostate cancer
Birth weight and prostate cancer risk and mortality
Circulating tumour cell mRNA expression in different stages of prostate cancer
Annual mpMRI AS and PI-RADS upgrading
Missed prostate cancer diagnoses during COVID-19 pandemic
Clinical characterisation of prostate cancer receiving conservative management
Circulating GDF15/MIC-1 as a marker of response to docetaxel
Prostate gland evaluation with MRI after focal therapy
Impact of genomic biomarkers on a clinical risk prediction model
Please login below to download this issue (PDF)